OClawVPS.com
Heran Partners
Edit

Heran Partners

https://heranpartners.com
Last activity: 18.02.2026
Active
Invests in categories: DataAnalyticsTechnologyPlatformHealthTechSoftwareResearchMedtechProductBusiness
Fuel for the next generation of HealthTech ventures. Heran Partners is a leading investment fund focussing on MedTech, HealthTech and ventures that combine both.
News
35
Portfolio
13
Persons
9
Mentions
7
Employees: 1-10

Portfolio 13

DateNameWebsiteTotal RaisedLocation
01.12.2023Broken Str...brokenstringbio.com$15MUnited Kin...
06.06.2023icometrixicometrix.com$18M-
06.06.2023Amaronamaron.be-Belgium, F...
06.06.2023ONTOFORCEontoforce.com-Belgium, E...
01.06.2023Hypervisio...hypervisionsurgical.com$8.1MUnited Kin...
04.04.2023ImmuneSpecimmunespec.com-Belgium, A...
22.09.2022Landing pa...aspect-analytics.com--
29.01.2020Lynxcarelynx.care$23.09MBelgium, F...
-PharmaFlui...pharmafluidics.com$8.79MBelgium, E...
-FOx BIOSYS...foxbiosystems.com$8.95MNetherland...
Show more

Persons 9

DateFirst NameLast NameTitleLinkedInLocation
-JorisMortelmansPartner / ...linkedin.c...-
-FilipMaesScientific...linkedin.c...-
-AnnieVereeckenFounding P...linkedin.c...-
-HermanVerrelstFounding P...linkedin.c...-
-EmkeGoijensOffice Man...linkedin.c...-
-Laurensde VriesAnalystlinkedin.c...-
-GeoffreyD'hondtInvestment...linkedin.c...-
-RafRoelandsInvestment...linkedin.c...-
-KatleenVandersmis...Managing P...linkedin.c...-

News 35

DateTitleDescription
14.11.2024FDA clearance for icobrain ariaWhy this news will impact the lives of people affected by Alzheimer’s disease: ● The first disease-modifying therapies for Alzheimer's disease have come to the market over the previous years – providing hope to the millions affected by Alzh...
10.09.2024DISQOVER 7: The next generation knowledge discovery platformDISQOVER excels in connecting siloed public, private, and licensed data through its knowledge graph, enabling comprehensive searches across disparate databases via a single interface. The new release features a fully redesigned user interfa...
20.08.2024Thirona's retina business unit acquired by Revenio GroupNijmegen, the Netherlands By joining forces with iCare, a market leader in eye care solutions, Thirona Retina is poised to enhance patient outcomes and drive innovation in eye care. Leveraging iCare’s market presence and expertise, Thirona ...
20.06.2024LynxCare appoints Jeanne Kehren to new CEOGeorges’ contributions have been foundational in establishing LynxCare as a leader in harnessing technologies to create healthcare data solutions. As LynxCare continues to grow, the company recognizes the importance of bringing in specializ...
16.02.2024Laurens de Vries joins HERAN Partners as AnalystBased on a shared passion for innovations on the intersection of medicine, engineering, and business, Laurens found his way to HERAN Partners. He understands that the road to market for medical ventures is paved with obstacles and that even...
19.09.202313th Investment for HERAN Partners: Broken String Biosciences (UK)Cambridge, UK: Broken String Biosciences, a genomics company building a technology platform to drive the development of cell and gene therapies that are safer by design, announced that it has closed a $15m Series A investment round, co-led ...
14.09.2023Thirona secures EUR 7,5m via investment round and EIC grantNijmegen, the Netherlands – Thirona, a global company specialized in advanced analysis of thoracic CT images with artificial intelligence, is thrilled to announce the successful completion of its new investment. The Company has secured EUR ...
05.09.2023FOx BIOSYSTEMS appoints Dr. Mark Truesdale as CEODiepenbeek, Belgium, September 5th, 2023
01.06.2023HERAN Partners co-leads the GBP 6,5m financing round of Hypervision Surgical to support the further development and commercial roll-out of their Hyperspectral Imaging platformHypervision Surgical, a London-based venture building an advanced surgical imaging and data analytics platform, announced the successful completion of an oversubscribed seed funding round, raising GBP 6,5M. By harnessing AI and clinical edg...
14.04.2023Discover how a sound collaboration between a start-up and a Venture Capital fund drives innovation in healthcare: FOx Biosystems case studyData processing, speed, and efficiency are of key importance in the field of pharmacological research. The importance of these factors was evident during the development of the first COVID-19 vaccines. With their White FOx technology, FOx B...
Show more

Mentions in press and media 7

DateTitleDescription
18.02.2026Pharmacelera Raises €6 Million To Expand In U.S. And Advance Quantum-AI PlatformPharmacelera, a deep tech company applying Quantum Mechanics and Artificial Intelligence to drug discovery, announced it has closed a €6 million investment round to accelerate its expansion into the United States and further develop its pro...
18.09.2023UK’s Broken String Biosciences raises €14M to develop, commercialise its INDUCE-seq tech: Know moreRead this article in: Cambridge-based Broken String Biosciences, a genomics company focused on creating safer cell and gene therapies, announced on Monday that it has raised $15M (approximately €14M) in a Series A round of funding. The inve...
06.09.2023How Pitango VC Is Planning to Invest Its New $175M Health Tech FundPitango Venture Capital, one of the largest venture capital firms in Israel, announced on Wednesday the closing of a new $175 million healthcare fund. The fund, named Pitango HealthTech II, is a sequel to Pitango’s first healthcare-dedicate...
01.06.2023HERAN Partners co-leads the GBP 6,5m financing round of Hypervision Surgical to support the further development and commercial roll-out of their Hyperspectral Imaging platformHypervision Surgical, a London-based venture building an advanced surgical imaging and data analytics platform, announced the successful completion of an oversubscribed seed funding round, raising GBP 6,5M. By harnessing AI and clinical edg...
24.03.2023HERAN Partners announces EUR 1,2m investment in ImmuneSpec to accelerate their advanced immunopeptidomics platformYou can find the original press release by ImmuneSpec here.
21.06.2022Belgian health tech Lynxcare unlocks €20 million to boost clinical insights for doctorsBelgian AI-powered clinical data platform LynxCare has raised €20 million in funding to accelerate the international rollout of its technology. The Series A investment was led by Swiss healthtech investor MTIP and joined by Elaia and the co...
-Belgian health tech Lynxcare unlocks €20 million to boost clinical insights for doctorsBelgian AI-powered clinical data platform LynxCare has raised €20 million in funding to accelerate the international rollout of its technology. The Series A investment was led by Swiss healthtech investor MTIP and joined by Elaia and the co...

Reviews 0

Sign up to leave a review

Sign up Log In